Skip Navigation


BJA Advance Access originally published online on February 20, 2006
British Journal of Anaesthesia 2006 96(4):437-443; doi:10.1093/bja/ael030
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/4/437    most recent
ael030v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schumacher, J.
Right arrow Articles by Klotz, K.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schumacher, J.
Right arrow Articles by Klotz, K.-F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats

J. Schumacher1,*, M. R. Puchakayala1, K. Binkowski2, W. Eichler2, A. Dendorfer3 and K.-F. Klotz2

1Department of Anaesthetics, Guy's and St Thomas' NHS Foundation Trust London, UK
2Department of Anaesthetics, University of Luebeck Germany
3Institute of Experimental and Clinical Pharmacology and Toxicology, University of Luebeck Germany

*Corresponding author: Department of Anaesthetics, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK. E-mail: jan.schumacher{at}gstt.sthames.nhs.uk

Background. To counteract the contribution of angiotensin II to shock-induced ischaemic organ damage pharmacologic blockade of the renin–angiotensin-system (RAS) is currently under investigation. To evaluate potential side-effects of RAS blockade regarding capillary leak, we studied alterations in microvascular permeability in various organs during haemorrhagic shock (HS) in rats pretreated with candesartan (AT1-receptor antagonism) or enalaprilat (ACE-inhibition).

Methods. Thirty-eight instrumented and anaesthetized animals received either candesartan, enalaprilat or placebo. Within each of the three groups 6–7 animals were exposed to HS and 6 animals of each group served as normovolaemic controls. After 30 min of shock, 50 mg kg–1 Evans blue (EB) was injected i.v. followed by a distribution period of 20 min. Exsanguination was performed with saline, before harvesting organs to quantify albumin-bound EB extravasation.

Results. To reduce cardiac output from 37.5 (1.3) to 20.4 (1.1) ml min–1 [mean (SEM)] in the shock groups, withdrawal of 4.0 (0.25) ml [mean (SEM)] blood was necessary. Simultaneously mean arterial pressure decreased from 77.5 (3.2) to 36.1 (2) mm Hg. Serum lactate increased significantly from 1.3 (0.1) to 3.5 (0.24) mmol litre–1. Treatment with candesartan increased EB extravasation in the kidney in normovolaemic controls. Specific AT1 and ACE-blockade before acute nonresuscitated HS significantly increased EB extravasation in the rat ileum by 53 and 66%, respectively.

Conclusion. This observation of increased microvascular albumin extravasation should be borne in mind for any interventional use of candesartan or enalaprilat during circulatory stress.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.